InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.07
(
-0.07%
)
Bitcoin
66,293.21
(
-0.52%
)
Post# of 252214
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119848
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 182322

Wednesday, 10/01/2014 10:18:19 AM

Wednesday, October 01, 2014 10:18:19 AM

Post# of 252214
ENTA—These will be the first data presented from the TURQUOISE-1* trial in patients with HIV/HCV co-infection and the CORAL-1 trial in patients who received liver transplants.

*Not to be confused with TURQUOISE-2 (the completed phase-3 trial in cirrhotic patients).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up